Anmol Rangoola, PA
Physician Assistant · Santa Monica, CANPI 1700320025
Payments from drug & device makers
Across 278 payments — averaging $105.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$13K
- Johnson & Johnson$6K
- Seagen Inc.$2K
- Janssen Scientific Affairs, LLC$1K
- Merck$972
- Astellas Pharma US Inc$683
- plus $5K from 38 others
What the payments were for
- Consulting fees$2,6779%
- Speaking & faculty fees$13,96548%
- Travel & lodging$3,42512%
- Food & beverage$9,03631%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 45 | $12,985 |
| Johnson & Johnson | 22 | $6,080 |
| Seagen Inc. | 5 | $1,823 |
| Janssen Scientific Affairs, LLC | 4 | $1,363 |
| Merck | 36 | $972 |
| Astellas Pharma US Inc | 19 | $683 |
| Bayer | 14 | $590 |
| AVEO Pharmaceuticals, Inc. | 5 | $450 |
| E.r. Squibb & Sons, L.L.C. | 16 | $422 |
| Blue Earth Diagnostics | 12 | $342 |
| Dendreon Pharmaceuticals LLC | 6 | $328 |
| Novartis | 13 | $307 |
| Progenics Pharmaceuticals, Inc. | 9 | $301 |
| Gilead | 7 | $294 |
| Urogen Pharma, Inc. | 5 | $249 |
| Eisai Inc. | 7 | $225 |
| EMD Serono, Inc. | 4 | $218 |
| Biotissue Holdings Inc. | 1 | $189 |
| Telix Pharmaceuticals | 1 | $167 |
| Myovant Sciences Inc. | 4 | $134 |
| Caris MPI, Inc. | 4 | $108 |
| Amgen | 5 | $103 |
| AbbVie | 3 | $99 |
| AstraZeneca | 4 | $98 |
| Lilly USA, LLC | 3 | $98 |
| Array Biopharma Inc | 4 | $81 |
| Sumitomo Pharma America, Inc. | 2 | $81 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Tersera Therapeutics LLC | 1 | $39 |
| Tempus AI, Inc | 1 | $32 |
| Sanofi | 1 | $30 |
| 180 Medical, Inc. | 1 | $30 |
| Incyte Corporation | 1 | $24 |
| Convatec Inc. | 1 | $23 |
| Intuitive Surgical | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| Foundation Medicine, Inc. | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Mimedx Group, Inc. | 1 | $20 |
| Smith+Nephew | 1 | $19 |
| Immunitybio, Inc. | 1 | $19 |
| Baxter Healthcare | 1 | $18 |
| Tolmar, Inc. | 1 | $17 |
| Myriad Genetic Laboratories, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,203 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 45 | $728,497 |
| Abiraterone Acetate | 136 | $380,186 |
| XtandiEnzalutamide | 15 | $212,734 |
| NubeqaDarolutamide | 14 | $182,507 |
| EliquisApixaban | 21 | $13,771 |
| SynthroidLevothyroxine Sodium | 21 | $1,531 |
| Hydrocortisone | 29 | $902 |
| Potassium Chloride | 23 | $673 |
| Prednisone | 121 | $631 |
| Temazepam | 12 | $581 |
| Levothyroxine Sodium | 31 | $542 |
| Gabapentin | 32 | $496 |
| Megestrol Acetate | 18 | $489 |
| Dexamethasone | 33 | $334 |
| Oxycodone Hcl | 12 | $334 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada | $6,080 | $728,49745 claims |
| Janssen Scientific Affairs, LLCAbiraterone Acetate | $1,363 | $380,186136 claims |
| Astellas Pharma US IncXtandi | $683 | $212,73415 claims |
| BayerNubeqa | $590 | $182,50714 claims |
| PfizerEliquis | $12,985 | $13,77121 claims |
| AbbVieSynthroid | $99 | $1,53121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Santa Monica
- Brittany LehmannSanta Monica$72K
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.